NCT07203287RecruitingPhase 4
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
The purpose of the study is to determine which combination of neuromuscular blocking agent and reversal agent is safer to use during anesthesia for patients with chronic kidney disease. The main question it aims to answer is "The use of Cisatracurium with neostigmine leads to less post-operative pulmonary complications than Rocuronium with sugammadex."
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 490 (estimated)
- First submitted
- 17 Sept 2025
- Start date
- 26 Aug 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Diseases
- Chronic kidney disease
- NCT number
- NCT07203287
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 490
- From 26 Aug 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients presenting for Renal Transplantation
- The surgery requires intubation post-operatively
Other illness
- Any patient with end stage renal disease
- Documented allergy to Rocuronium, Sugammadex, Cisatracurium or Neostigmine
Age
- Any patient under the age of 18
- Any patient over the age of 80
Other
- Any patient requiring dialysis
- Pregnant Female
- Any patient in the correctional system
- Urgent or Emergent procedure
Who the study is looking for
- The subject is able and willing to provide and sign informed consent
- The subject must be between 18 and 80 years of age
- The subject should have chronic kidney disease as defined by glomerular filtration rate
- The surgery must require general anesthesia with endotracheal intubation and neuromuscular blockade
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas Medical Branch Coordinator of this site? Confirm its status | Galveston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.